Top Ideas
Polycom Offers Solid Risk And Reward Heading Into 2014
by BuyTheDip SellTheRip
Editor's notes: Significant share buybacks, an attractive product line, and on-going cost cutting efforts at PLCM have the stock poised to outperform. Stock could see upside of 20% in 2014.
Rosetta Stone's Share Price Is Speaking Volumes
by Mike Arnold
Editor's notes: Temporary pressures have pushed shares of RST to a 52-week low. Simple continued execution could lead to 80% upside.
Micronet Enertec: Post-Merger Messy Financials Obscure Explosive Growth Potential
by Igor Novgorodtsev
Editor's notes: Investors don't have a long history of results to reference, and this has created an opportunity. Its core business alone may be worth 250% of MICT's value.
Stocks Moving From Top Ideas
Last Tuesday, Fincom Investment Partners called out Wellgreen Platinum as a gem among the rubble of mining stocks, and projected the stock could rise as much as 1,000%. Shares are +35% since. Read article »
On July 1, tech expert Ashraf Eassa predicted significant opportunity beyond near-term concerns for shares of semiconductor maker Silicon Motion. After a blowout earnings report Monday, the stock is now +63% to date. Read article »
Long Ideas
David Slays Goliath: Vringo Awarded Billion-Dollar Victory Over Google by Justin Giles
PURE Bioscience Organizes To Take Prominent Role In Food Safety by Barry Wald
Bank Of America: Billions In Additional Profits Coming, Here's How by Josh Arnold
Special Situations Update: NuPathe Correction by Jae Jun
Tesla: Time To Take Profits? by Bill Maurer
Honeywell - Growth, Margin Expansion At A Fair Price by The Value Investor
Cree: Increased LED Adoption Will Help Future Growth by Fusion Research
Patents And SDN Make Alcatel-Lucent A Great Long-Term Investment by Almario Alexej Alcaraz
The 2014 Homebuilder Breakout Begins Early With A Very Bullish D.R. Horton by Dr. Duru
Eaton Is Heading In The Right Direction by Blackstone Equity Research
Don't Underestimate Amgen: Part 2A, Cardiovascular And Oncology Pipeline Products by Stephen Barnes
FS Bancorp - Misunderstood Gem, An Upside Catalyst In 3 Trading Days by The Capitalist
Sirius XM: $3.38? Liberty's Deal Is Not A Sure Thing by Stephen Faulkner
IBM: A Contrarian View by Stock Gamer
IBM: Answering Buffett's Prayers? by YCharts
Apple: Cheap iPhone Now Appears A Certainty by Ed McKernan
A $10 Billion Market By 2022: Pharmacyclic's Piece Of It by YCharts
Pressure BioSciences: A Low Risk, High Reward Stock In The Biotech Space by Grant Zeng
MacroSolve: An Ignored, But Potentially High-Yield Patent Play? by Markman Advisors
Las Vegas Sands: The Right Place To Put Your Money by Alpha Strategist
General Electric: Buy The Dip? by Albert Alfonso
Stereotaxis - Interview Of Experienced Doctor With Stereotaxis' Robotic System by Overlooked and Underfollowed
Synergy Resources Offering A Lot Of Exploration Upside by Stephen Simpson, CFA
A Contrarian View On The Impact Of Facebook's Demographic Shift by George Ronan
Zacks' Bull Of The Day: White Mountains Insurance by Zacks Investment Research
Valuing Hawaiian Electric Industries by Christopher Lum Lee
Look For Tesla To Dramatically Raise Its Guidance: $500 Target Remains by Green Energy Addict
Timmins Gold: Soaring Production Cost Estimates Detract From Resource And Production Growth by Ben Kramer-Miller
FactSet Research Is Well Positioned, But Fairly Valued by Ashleigh Rogers
Equinix Debt And Liabilities Analysis by FAF Research
Melcor Developments Is Worth A Look by Mike Arnold
Rosetta Resources Should See Imminent Upside by Itinerant
Will Groupon Be The Next Great Comeback? by Scott Ryan
J.C. Penney: Why Preserve NOLs If There Aren't Future Profits? by Dante's Investing Ideas
O2Micro International, A Turnaround Story That Trades Close To Cash Value by Ken Nagy
Rayonier Switching It Up As Its Prospects Diverge by Stephen Simpson, CFA
Problems At Nokia Set To Benefit Alcatel-Lucent by Chris Lau
Elecsys: A Compelling Micro Cap Strategically Positioned For Growth In The Internet Of Things by Dave Kelly
Korn/Ferry Will Be A Leading Beneficiary From Any Employment Improvement by Ashleigh Rogers
Unlocking The Value Trapped In Facebook by Lenny Grover
Renesola: Poised To Become Profitable This Year, Up To 300% Stock Upside In 2014 by Rohit Singla
GigaMedia Ltd.: A $1 Stock With $1.47/Share Cash And Significant Growth Prospects by Micro-Cap Gem Finder
Atwood Oceanics Cheap Due To Unrelated Weakness by Illuminati Investments
Simply Loving Ford In 2014 by Quoth the Raven
Will Ford's Stock Catch Up With The Company? by BubbleBustInvesting
China Telecom's $400mm Medical Smartphone Agreement Is Great News For China Techfaith Wireless by John Sheehy
Teradyne: An Attractive Tech Stock by Arie Goren
Camtek: Modeling The GreenJet Effect by Jonathan Fishman
Good Or Bad, PBF Energy Won't Be Boring by Stephen Simpson, CFA
The NuPathe Contingent Value Right: Paying 25 Cents For A Dollar by Ruerd Heeg
Apple Tanking - On Its Way To $650? by Quoth the Raven
I'm Still Not Impressed With Copper Fox Metals by The Investment Doctor
Digital Cinema Destinations Has Much More Upside Than Downside by Philip Mause
Ecosystem Maths by Benedict Evans
My Other Phone Is A BlackBerry by Redrut
Costar Technologies Provides Security Against Theft, Yet Its Stock Is A Steal by William Garrison
Antero Resources' Massive Utica Well Results by Josh Young
Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin by Matija Snuderl
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan by Dendrite Research
General Dynamics: Sound And Solid by Confero
Doubling Down On Apple by Bret Jensen
Apple: Is The iPhone 6 NFC Rumor True? by Prescient Investment Analysis
Encana: Strengthening Performance In Duverney by Gabe Ortt
Warren Resources: Natural Gas Spike Could Power Shares by Bret Jensen
Microsoft Counting On Azure And Surface by Sramana Mitra
Unconventional Thoughts On Best Buy by The Financial Lexicon
Neuralstem: Sizing Up Potential Key Events Of 2014 by Smith On Stocks
Crew Energy Trading At 57% Of NAV by Chris Damas
Does Accuray's Recent Unusual Bullish Options Activity Signal A Rally In The Stock Soon? by StockMatusow
Oramed's Data Will Define A New Standard For Diabetes by Sharon di Stefano
Short Ideas
Apple: Between Icahn And A Much Harder Rock by Benedict Tubuo (Beevest)
LiveDeal: 50% Downside Possible In This Promoted Stock by Christopher Drose
Canada Probing Herbalife, Eh? by Quoth the Raven
Fred's Inc.: Investor's Optimism About Industry Has Led To A Valuation Disconnect by Balanced Investing
Rent-A-Center Prepares To Release by Brent Shelton
Quick Picks & Lists
Investors Should Avoid The 3D Space This Year by George Kesarios
3D - The Printing Revolution - Bust Before The Boom? by Serge d'Adesky
The Best Performers Of Seeking Alpha: Vol. 1 by Peter Wicks
ModernGraham Annual Valuation Of Weyerhaeuser Company by Benjamin Clark
What Future Does Online Gambling Hold For Investors? by Nicholas Kitonyi
Why Property And Casualty Insurers Are Great Value Plays For 2014 by Kapitall
Low-Priced Stocks Worth Buying: Round 9 (Advanced Semiconductor Engineering, Jive Software, And United Microelectronic) by Stan Stafford
Zacks' Bear Of The Day: Alico by Zacks Investment Research
PetroChina: Discounted Growth Play With Significant Upside by CJ Capital Research
2 Attractive $8 A Share Energy Plays by Bret Jensen
Buy The Pullback In These 2 Cheap Hedge Fund Turnaround Stocks by Hawkinvest
Take The Emotion Out Of Apple by Stock Traders Daily
ModernGraham Annual Valuation Of Williams Companies by Benjamin Clark
Cramer's Picks
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) by SA Editor Miriam Metzinger
Cramer's Mad Money - Lumpy Versus Linear (1/28/14) by SA Editor Miriam Metzinger
Fund Holdings
Growth Fund Of The Year: Stock Picks by YCharts
Insider Ownership
Northern Trust: 4 Different Insiders Have Sold Shares This Year by Markus Aarnio
Palo Alto Networks: 3 Different Insiders Have Sold Shares This Year by Markus Aarnio
Sonic: 4 Different Insiders Have Sold Shares This Year by Markus Aarnio
IPO Analysis
Stay Away From The NephroGenex IPO (And Short It Later) by biotech2infinity
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario